Literature DB >> 3372957

European interlaboratory comparison of serum thyroglobulin measurement.

U Feldt-Rasmussen1, M Schlumberger.   

Abstract

A European interlaboratory comparison of serum thyroglobulin measurements was performed after an initiative from the European Organization of Research and Therapy of Cancer. Fifty-two laboratories were addressed and 45 of these (83%) participated in the study by measuring serum thyroglobulin and its autoantibody in 5 thyroglobulin containing sera. Thyroglobulin antibodies were added to two of the sera. Two commercial kits were used by a large number of the laboratories (11 and 8, respectively). Each kit showed a reasonably low interlaboratory coefficient of variation at concentrations above 25 micrograms/l, but with discrepancy between the methods. The remaining miscellaneous methods (24) showed a variation above 65% in all samples. In all laboratories the addition of thyroglobulin antibodies resulted in false thyroglobulin measurements with either elevated or depressed levels. It is concluded that a reference calibrator for serum thyroglobulin is strongly needed as the first essential step towards interlaboratory standardization of serum thyroglobulin, thereby opening a possibility for multicentre studies of its value in the post-therapy follow-up of patients with differentiated thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372957     DOI: 10.1007/BF03350129

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Control of thyroglobulin synthesis and secretion. (First of two parts).

Authors:  A J Van Herle; G Vassart; J E Dumont
Journal:  N Engl J Med       Date:  1979-08-02       Impact factor: 91.245

2.  Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies.

Authors:  A B Schneider; R Pervos
Journal:  J Clin Endocrinol Metab       Date:  1978-07       Impact factor: 5.958

3.  Clearance of normal and tumor-related thyroglobulin from the circulation of rats: role of the terminal sialic acid residues.

Authors:  K Ikekubo; R Pervos; A B Schneider
Journal:  Metabolism       Date:  1980-07       Impact factor: 8.694

4.  Critical analysis of [131I]- and [125I]human thyroglobulin labels for radioimmunoassay use.

Authors:  M Schlumberger; A J Van Herle
Journal:  J Clin Endocrinol Metab       Date:  1982-03       Impact factor: 5.958

5.  Evaluation of a solid-phase immunoradiometric assay (IRMA) for serum thyroglobulin: effect of anti-thyroglobulin autoantibody.

Authors:  S Mariotti; C Cupini; C Giani; R Lari; E Rolleri; A Falco; M Marchisio; A Pinchera
Journal:  Clin Chim Acta       Date:  1982-08-18       Impact factor: 3.786

6.  The effect of [125I]thyroglobulin tracer heterogeneity on serum Tg RIA measurement.

Authors:  C A Spencer; B W Platler; J T Nicoloff
Journal:  Clin Chim Acta       Date:  1985-12-13       Impact factor: 3.786

7.  Influence of thyroid substitution therapy and thyroid autoantibodies on the value of serum thyroglobulin in recurring thyroid cancer.

Authors:  U Feldt-Rasmussen; I Holten; H S Hansen
Journal:  Cancer       Date:  1983-06-15       Impact factor: 6.860

8.  Purification of human thyroglobulin for radioimmunoassay and testing by ultracentrifugal analysis and immunoelectrophoresis.

Authors:  U Feldt-Rasmussen
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

9.  Endemic goiter in Vietnam.

Authors:  J M Hershman; D T Due; B Sharp; L My; J R Kent; L N Binh; A W Reed; L D Phuc; A J Van Herle; N A Thai; T X Troung; N V Van; M Sugawara; A E Pekary
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

10.  Production and in vitro utilization of monoclonal antibodies to human thyroglobulin.

Authors:  D Bellet; M Schlumberger; J M Bidart; M Assicot; B Caillou; P Motte; A Vignal; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1983-03       Impact factor: 5.958

View more
  9 in total

1.  Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer.

Authors:  D Rubello; M E Girelli; D Casara; M Piccolo; A Perin; B Busnardo
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

Review 2.  Thyroglobulin as a biomarker of iodine deficiency: a review.

Authors:  Zheng Feei Ma; Sheila A Skeaff
Journal:  Thyroid       Date:  2014-06-12       Impact factor: 6.568

3.  False positive 131I total body scan due to an ectasia of the common carotidis.

Authors:  D Giuffrida; M R Garofalo; G Cacciaguerra; V Freni; A Ippolito; C Regalbuto; M G Santonocito; A Belfiore
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

4.  A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients.

Authors:  M Schlumberger; P Fragu; P Gardet; J Lumbroso; D Violot; C Parmentier
Journal:  Eur J Nucl Med       Date:  1991

5.  Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients.

Authors:  Marijana Stanojevic; Svetlana Savin; Dubravka Cvejic; Aleksandar Djukic; Marija Jeremic; Snezana Zivancević Simonovic
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

6.  Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma.

Authors:  A J Brendel; B Lambert; M Guyot; R Jeandot; H Dubourg; P Roger; S Wynchauk; G Manciet; G Lefort
Journal:  Eur J Nucl Med       Date:  1990

Review 7.  How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies.

Authors:  Carole Spencer; Jonathan LoPresti; Shireen Fatemi
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

8.  Serum thyroglobulin reference intervals in regions with adequate and more than adequate iodine intake.

Authors:  Zhaojun Wang; Hanyi Zhang; Xiaowen Zhang; Jie Sun; Cheng Han; Chenyan Li; Yongze Li; Xiaochun Teng; Chenling Fan; Aihua Liu; Zhongyan Shan; Chao Liu; Jianping Weng; Weiping Teng
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 9.  Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.

Authors:  Luca Giovanella; Penelope M Clark; Luca Chiovato; Leonidas Duntas; Rossella Elisei; Ulla Feldt-Rasmussen; Laurence Leenhardt; Markus Luster; Camilla Schalin-Jäntti; Matthias Schott; Ettore Seregni; Herald Rimmele; Jan Smit; Frederik A Verburg
Journal:  Eur J Endocrinol       Date:  2014-04-17       Impact factor: 6.664

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.